Histamine Receptors Regulate the Activity, Surface Expression, and Phosphorylation of Serotonin Transporters.


Journal

ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337

Informations de publication

Date de publication:
05 02 2020
Historique:
pubmed: 10 1 2020
medline: 4 3 2021
entrez: 10 1 2020
Statut: ppublish

Résumé

Reuptake and clearance of released serotonin (5-HT) are critical in serotonergic neurotransmission. Serotonin transporter (SERT) is mainly responsible for clearing the extracellular 5-HT. Controlled trafficking, phosphorylation, and protein stability have been attributed to robust SERT activity. H

Identifiants

pubmed: 31916747
doi: 10.1021/acschemneuro.9b00664
pmc: PMC7004881
mid: NIHMS1068244
doi:

Substances chimiques

Receptors, Histamine 0
Serotonin Plasma Membrane Transport Proteins 0
Serotonin 333DO1RDJY

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

466-476

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH062612
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112731
Pays : United States

Références

Physiol Rev. 2008 Jul;88(3):1183-241
pubmed: 18626069
Trends Pharmacol Sci. 2005 Nov;26(11):578-86
pubmed: 16183137
J Neurosci Methods. 2004 Dec 30;140(1-2):169-81
pubmed: 15589347
J Neurosci. 2004 Oct 6;24(40):8704-10
pubmed: 15470136
J Neurosci. 2007 Jan 17;27(3):684-91
pubmed: 17234600
J Biol Chem. 2016 Sep 30;291(40):21042-21052
pubmed: 27510032
Int J Biochem Cell Biol. 2001 May;33(5):439-55
pubmed: 11331200
J Neurosci. 2005 Jan 5;25(1):29-41
pubmed: 15634764
Mol Pharmacol. 1998 Apr;53(4):649-55
pubmed: 9547354
J Pharmacol Exp Ther. 2003 Jun;305(3):956-65
pubmed: 12626658
J Biol Chem. 1998 Jan 23;273(4):2458-66
pubmed: 9442097
Annu Rev Pharmacol Toxicol. 2007;47:401-41
pubmed: 17067279
Neuropharmacology. 2016 Jul;106:85-90
pubmed: 26282120
Pharmacol Ther. 2011 Feb;129(2):220-38
pubmed: 20951731
J Neurochem. 2007 Oct;103(1):248-58
pubmed: 17623045
J Neurosci. 2013 Oct 9;33(41):16189-99
pubmed: 24107951
Synapse. 2012 Dec;66(12):1024-34
pubmed: 22961814
Mol Pharmacol. 2005 Jan;67(1):195-203
pubmed: 15465923
Psychopharmacology (Berl). 2009 Aug;205(2):177-87
pubmed: 19357839
Transl Psychiatry. 2017 Jan 24;7(1):e1013
pubmed: 28117842
Synapse. 1994 May;17(1):1-15
pubmed: 8042142
Mol Pharmacol. 2005 Jun;67(6):2077-87
pubmed: 15774771
Mov Disord. 2013 Aug;28(9):1263-70
pubmed: 23630162
Neuroscience. 1998 Dec;87(4):797-805
pubmed: 9759967
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5469-74
pubmed: 22431635
Brain Res. 1996 Oct 28;738(1):96-102
pubmed: 8949931
J Biol Chem. 2007 Apr 20;282(16):11639-47
pubmed: 17310063
Nature. 2000 Dec 14;408(6814):860-4
pubmed: 11130725
Mol Pharmacol. 1999 Jun;55(6):1101-7
pubmed: 10347254
Handb Exp Pharmacol. 2017;241:189-215
pubmed: 28233179
Science. 1999 Jul 30;285(5428):763-6
pubmed: 10427004
Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):513-9
pubmed: 1965326
Mol Pharmacol. 2012 Jan;81(1):73-85
pubmed: 21992875
J Neurosci. 2000 Oct 15;20(20):7571-8
pubmed: 11027216
Behav Brain Res. 2004 Sep 23;154(1):211-9
pubmed: 15302127
J Neurosci. 2003 Oct 8;23(27):9016-23
pubmed: 14534235
Neural Plast. 2011;2011:328602
pubmed: 21876818
Biochem J. 2015 May 15;468(1):177-90
pubmed: 25761794
Pharmacol Ther. 2017 Jul;175:116-132
pubmed: 28223162
J Biol Chem. 1994 May 20;269(20):14424-9
pubmed: 8182048
Pharmacol Rev. 2016 Oct;68(4):888-953
pubmed: 27591044
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2542-6
pubmed: 7681602
Biochem Pharmacol. 2007 Apr 15;73(8):1157-71
pubmed: 17288995
Neuroreport. 2000 Sep 28;11(14):3237-41
pubmed: 11043555
Pharmacol Rev. 2015 Jul;67(3):601-55
pubmed: 26084539
J Pharmacol Exp Ther. 1999 Sep;290(3):1427-35
pubmed: 10454522
Neuropharmacology. 2008 Aug;55(2):190-7
pubmed: 18547596
Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):588-90
pubmed: 3412497
CNS Neurosci Ther. 2017 Apr;23(4):301-309
pubmed: 28168839
Neuropharmacology. 2017 Feb;113(Pt A):281-292
pubmed: 27743931
Neurochem Int. 2014 Jul;73:127-31
pubmed: 24246466
Neuroscience. 2002;114(1):173-93
pubmed: 12207964
Curr Opin Pharmacol. 2011 Feb;11(1):3-10
pubmed: 21439906
FASEB J. 2014 Feb;28(2):771-80
pubmed: 24192459
Neurosci Biobehav Rev. 2014 Nov;47:101-21
pubmed: 25102165
Neuropharmacology. 2008 Oct;55(5):763-70
pubmed: 18602929
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5493-8
pubmed: 22431634
Mol Pharmacol. 2001 Jan;59(1):1-8
pubmed: 11125017
Nat Rev Neurosci. 2003 Feb;4(2):121-30
pubmed: 12563283
Adv Exp Med Biol. 2010;709:95-107
pubmed: 21618891

Auteurs

Balasubramaniam Annamalai (B)

Department of Neurosciences , Medical University of South Carolina , Charleston , South Carolina 29425 , United States.

Durairaj Ragu Varman (D)

Department of Pharmacology and Toxicology , Virginia Commonwealth University , Richmond , Virginia 23298 , United States.

Rebecca E Horton (RE)

Department of Cellular and Integrative Physiology , University of Texas Health Science Center at San Antonio , San Antonio , Texas 78229 , United States.

Lynette C Daws (LC)

Department of Cellular and Integrative Physiology , University of Texas Health Science Center at San Antonio , San Antonio , Texas 78229 , United States.

Lankupalle D Jayanthi (LD)

Department of Pharmacology and Toxicology , Virginia Commonwealth University , Richmond , Virginia 23298 , United States.

Sammanda Ramamoorthy (S)

Department of Pharmacology and Toxicology , Virginia Commonwealth University , Richmond , Virginia 23298 , United States.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH